Cyclooxygenase-2 (COX2) and p53 protein expression are interdependent in breast cancer but not associated with clinico-pathological surrogate subtypes, tumor aggressiveness and patient survival.
Author:
Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Publisher
Elsevier BV
Subject
Cell Biology,Histology,General Medicine
Reference40 articles.
1. Microvessel density and status of p53 protein as potential prognostic factors for adjuvant anthracycline chemotherapy in retrospective analysis of early breast cancer patients group;Biesaga;Pathol. Oncol. Res.,2012
2. Ki67 index, HER2 status, and prognosis of patients with Luminal B breast cancer;Cheang;J. Natl. Cancer Inst.,2009
3. COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patients;Chikman;Med. Oncol.,2014
4. Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma;Cho;Breast,2006
5. Paradoxic effects of metformin on endothelial cells and angiogenesis;Dallaglio;Carcinogenesis,2014
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cyclooxygenase-2 immunohistochemical expression is associated with worse prognosis in breast cancer;Saudi Medical Journal;2022-07
2. Immunohistochemical Expression of Cyclooxygenase-2 and Its Relationship With Prognostic Parameters in Breast Cancer;Cyprus Journal of Medical Sciences;2021-04-26
3. S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue;npj Breast Cancer;2020-11-24
4. MiR-548c-3p inhibits the proliferation, migration and invasion of human breast cancer cell by targeting E2F3;Cytotechnology;2020-09-09
5. S-nitrosylated and non-nitrosylated COX2 has differential expression and distinct subcellular localization in normal and breast cancer tissue;2020-05-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3